August 3, 2012
Shionogi & Co., Ltd. announced on August 1 that it filed a new drug application (NDA) on July 27 in Japan for metreleptin, a treatment for lipodystrophy. Metreleptin is a recombinant human leptin licensed from Amylin Pharmaceuticals of the US...read more